Eculizumab in Pediatric Dense Deposit Disease (Q36123605)

12 August 2017

Eculizumab in Pediatric Dense Deposit Disease (English)

1 reference

12 August 2017

4

Sandrine Florquin

2 references

ORCID Public Data File 2021

12 August 2017

Michiel J S Oosterveld

1

object named as

Michiel J S Oosterveld

1 reference

12 August 2017

Mark R Garrelfs

2

1 reference

12 August 2017

Bernd Hoppe

3

1 reference

12 August 2017

Joris J T H Roelofs

5

1 reference

12 August 2017

L P van den Heuvel

6

1 reference

12 August 2017

Kerstin Amann

7

1 reference

12 August 2017

Jean-Claude Davin

8

1 reference

12 August 2017

Antonia H M Bouts

9

1 reference

12 August 2017

Pietrik J Schriemer

10

1 reference

12 August 2017

Jaap W Groothoff

11

1 reference

12 August 2017

27 August 2015

1 reference

Clinical Journal of the American Society of Nephrology

12 August 2017

1 reference

12 August 2017

10

1 reference

12 August 2017

10

1 reference

12 August 2017

1773-1782

1 reference

C3 glomerulopathy: consensus report

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Toward a working definition of C3 glomerulopathy by immunofluorescence

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

An international serum standard for application in assays to detect human complement activation products

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Eculizumab and recurrent C3 glomerulonephritis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Treatment options for C3 glomerulopathy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Eculizumab for the Treatment of Dense-Deposit Disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Eculizumab in a patient with dense-deposit disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Eculizumab for dense deposit disease and C3 glomerulonephritis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Clinical features and outcomes of 98 children and adults with dense deposit disease.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

C3 glomerulopathy: a new classification

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Membranoproliferative glomerulonephritis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

New approaches to the treatment of dense deposit disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Blockade of alternative complement pathway in dense deposit disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Pathology after eculizumab in dense deposit disease and C3 GN.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

C3 glomerulopathy: what's in a name?

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594061

Eculizumab therapy in a patient with dense-deposit disease associated with partial lipodystropy

23 September 2018

1 reference

12 December 2020

Eculizumab in dense-deposit disease after renal transplantation

1 reference

12 December 2020

A new screening test for C3 nephritis factor based on a stable cell bound convertase on sheep erythrocytes

1 reference

12 December 2020

Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies

1 reference

12 December 2020

Rituximab fails where eculizumab restores renal function in C3nef-related DDD

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.01360215

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

26316621

1 reference